or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    AVBP C ArriVent BioPharma, Inc. -2.39
    PYXS C Pyxis Oncology, Inc. -44.63
    IBRX C ImmunityBio, Inc. 4.72
    PSTX D Poseida Therapeutics, Inc. -0.18
    CASI D CASI Pharmaceuticals, Inc. -0.19
    MRKR D Marker Therapeutics, Inc. -6.27
    OTLK D Outlook Therapeutics, Inc. -2.27
    CRDF D Cardiff Oncology, Inc. -0.59
    CLDX D Celldex Therapeutics, Inc. -0.13
    RCUS F Arcus Biosciences, Inc. -1.98
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Immune System Immunotherapy Medicine Biopharmaceutical Clinical Medicine Solid Tumors Virotherapy Acute Myeloid Leukemia Antineoplastic Drugs Biology Biotechnology Cell Therapy Kinase 1 Lung Cancer Non Small Cell Lung Carcinoma Toxins Treatment Of Cancer Tumor Adoptive Cell Transfer

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 0.93
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.55
    FPXE D First Trust IPOX Europe Equity Opportunities ETF 0.31
    BMED D BlackRock Future Health ETF 0.12
    KOMP B SPDR Kensho New Economies Composite ETF 0.05
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare CNCR to BBC Compare CNCR to BMED Compare FPXE to BMED

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Nov 21 PYXS Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 20 IBRX High Growth Tech Stocks To Watch In November 2024
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 19 RCUS Arcus Biosciences to Participate in Two Upcoming Investor Conferences
        Nov 19 IBRX ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 17 MRKR Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 CASI CASI Pharmaceuticals reports Q3 results
        Nov 15 CASI CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
        Nov 15 AVBP ArriVent BioPharma GAAP EPS of -$0.61 beats by $0.11
        Nov 14 MRKR Marker Therapeutics GAAP EPS of -$0.26, revenue of $1.93M
        Nov 14 MRKR Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Immune System Immunotherapy Medicine Biopharmaceutical Clinical Medicine Solid Tumors Virotherapy Acute Myeloid Leukemia Antineoplastic Drugs Biology Biotechnology Cell Therapy Kinase 1 Lung Cancer Non Small Cell Lung Carcinoma Toxins Treatment Of Cancer Tumor Adoptive Cell Transfer
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags